来源:[1] BioMarin 将以 48 亿美元收购 Amicus Therapeutics,押注罕见病领域 - 路透社 (https://www.reuters.com/legal/transactional/b ...)[2] BioMarin 将以 48 亿美元全现金交易收购 Amicus Therapeutics,扩大罕见病药物组合 - ts2.tech (https://ts2.tech/en/biomarin-to-acquire-amicu ...)[3] BioMarin 将以 48 亿美元收购 Amicus Therapeutics - CNBC (https://www.cnbc.com/2025/12/19/biomarin-to-a ...)